...
首页> 外文期刊>Open access Rheumatology: Research and Reviews >Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center
【24h】

Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center

机译:意大利类风湿关节炎患者的死亡率:证据表明三级中心的患者因癌症和感染而死亡率低

获取原文
           

摘要

Objectives: Mortality in patients with rheumatoid arthritis (RA) has never been investigated in Italy. This study is devoted to investigating all the distinct causes of mortality in Italian RA patients. Methods: Clinical charts of patients consecutively admitted to an Italian tertiary center, from January 1, 2008 to December 31, 2014, were reviewed. Mortality rates (incidence mortality rate [IMR] and standardized mortality rate [SMR]) and causes of death as assessed at December 31, 2015, were registered. Mortality rates detected in our series were compared to those reported in other European cohorts and in the general Italian population. Results: Six hundred and eight patients were observed for a median of 3.51 years. Overall IMR was 0.79 deaths/100 person-years. No significant difference between our IMR and that reported in Italian population by the National Institute of Statistics was observed. All-cause and neoplasm IMRs in our series were found to be significantly lower than that reported in the Norfolk Arthritis Registry, while no difference was detected in cardiovascular (CV) mortality. On the other hand, all causes and CV SMRs in our series were found to be higher than that reported in the general Italian population, while cancer and infectious SMRs were found to be lower. Conclusion: In our series, RA patients had an increased all-cause mortality, and in particular an increased death rate due to CV. However, a lower death rate due to cancer and infections was observed. This figure might be due to the careful follow-up of RA patients in tertiary centers, and the results underlines the need to improve the management of CV risk.
机译:目的:风湿性关节炎(RA)患者的死亡率从未在意大利进行过调查。这项研究致力于调查意大利RA患者死亡的所有不同原因。方法:回顾性分析了自2008年1月1日至2014年12月31日在意大利第三中心接受连续治疗的患者的临床病历。记录了2015年12月31日评估的死亡率(发病率[IMR]和标准死亡率[SMR])和死亡原因。将我们系列中检测到的死亡率与其他欧洲人群和意大利一般人群中报告的死亡率进行了比较。结果:观察到608位患者,中位时间为3.51年。整体IMR为0.79死亡/ 100人年。我们的IMR与国家统计局在意大利人口中报告的IMR之间没有显着差异。我们的系列中的全因和肿瘤IMRs均明显低于诺福克关节炎注册中心的报告,而心血管(CV)死亡率无差异。另一方面,发现我们系列中的所有原因和CV SMR均高于意大利普通人群中报告的水平,而癌症和传染性SMR则较低。结论:在我们的系列研究中,RA患者的全因死亡率增加,尤其是CV导致的死亡率增加。但是,观察到由于癌症和感染导致的死亡率降低。这个数字可能是由于在三级中心对RA患者进行了认真的随访,结果强调需要改善CV风险的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号